Royalty Pharma Operating Lease Liability Payments - 2026 (Lessee) increased by 0.1% to $3.73M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Allows for precise modeling of fixed costs in the specified future period.
The specific cash outflows contractually obligated for operating leases during the calendar year 2026. This provides a s...
Standard disclosure for specific future year lease obligations.
lease_liability_payments_2026_lessee| Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $3.72M | $3.72M | $3.73M |
| QoQ Change | — | +0.0% | +0.1% |